Hepatitis B Immunoglobulin

Brand: CSL Behring
Category: Finished Products

In case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown).
In haemodialysed patients, until vaccination has become effective.
In the newborn of a hepatitis B virus carrier-mother or a mother with unknown HbsAg-status.
In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.
National and/or WHO guidelines regarding protection against hepatitis B infection should be observed.